Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Apr 2;143(1):31-7.
doi: 10.1016/j.jconrel.2009.12.019. Epub 2010 Jan 5.

Threshold size for optimal passive pulmonary targeting and retention of rigid microparticles in rats

Affiliations

Threshold size for optimal passive pulmonary targeting and retention of rigid microparticles in rats

Hilliard L Kutscher et al. J Control Release. .

Abstract

The relationship between microparticle (MP) size and lung targeting efficiency, intra-lung distribution and retention time was systematically studied after intravenous administration of rigid fluorescent polystyrene MPs of various sizes (2, 3, 6 and 10 microm) to Sprague Dawley rats. Total fluorescence was assessed and it was found that 2 microm and 3 microm MPs readily passed through the lung to the liver and spleen while 10 microm MPs were completely entrapped in the lung for the one-week duration of the study. Approximately 84% of 6 microm MPs that were initially entrapped in the lung were cleared over the next 2 days and 15% were cleared over the remaining 5 days. A Caliper IVIS 100 small animal imaging system confirmed that 3 microm MPs were not retained in the lung but that 6 microm and 10 microm MPs were widely distributed throughout the lung. Moreover, histologic examination showed MP entrapment in capillaries but not arterioles. These studies suggest that for rigid MPs the optimal size range required to achieve transient but highly efficiently targeting to pulmonary capillaries after IV injection is >6 microm but <10 microm in rats and that systemic administration of optimally sized MPs may be an efficient alternative to currently used inhalation-based delivery to the lung.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Numeric (solid) and Volumetric (dashed) distribution of polystyrene MPs: 3 μm (red); 6 μm (green), 10 μm (blue). The size of the 3 μm, 6 μm and 10 μm polystyrene MPs as reported by the manufacturer were: 3.005 ± 0.112 μm, 6.098 ± 0.573 μm, 10.94 ± 0.396 μm, respectively; the volumetrically measured size of polystyrene MPs were: 3.066 ± 0.236 μm, 5.915 ± 0.205 μm, and 11.06 ± 0.309 μm, respectively.
Fig. 2
Fig. 2
SEM of 6 μm polystyrene MPs. MPs appear to be discrete with a smooth surface and have low polydispersity.
Fig. 3
Fig. 3
Biodistribution studies of MPs in the filter organs and hearts of healthy rats was determined using a fluorescent plate reader (n = 3) at different time points after IV injection: (A) 2 μm; (B) 3 μm; (C) 6 μm; and (D) 10 μm.
Fig. 4
Fig. 4
A representative picture of the spatial distribution of 3, 6 and 10 μm fluorescently labeled carboxylate polystyrene MPs in the lung of healthy rats, imaged using the IVIS® 100 at 1 hour, 12 hours, 24 hours and 168 hours post injection. The MPs were highly distributed throughout the lung tissue.
Fig. 5
Fig. 5
H & E stained healthy rat lung in GMA polymer matrix: control rat lung (Panel A & B); rat lung 48 hours after administration of 10 μm MPs (Panel C & D). MPs are indicated by arrows; showing they were entrapped in the pulmonary septal microvessels. Magnification of Panels A & C: 20x; Panels B & D: 60x.

Similar articles

Cited by

References

    1. Pritchard JN. The influence of lung deposition on clinical response. J Aerosol Med. 2001;14(Suppl 1):S19–26. - PubMed
    1. Derendorf H, Hochhaus G, Mollmann H. Evaluation of pulmonary absorption using pharmacokinetic methods. J Aerosol Med. 2001;14(Suppl 1):S9–17. - PubMed
    1. Washington N, Washington C, Wilson CG. Physiological pharmaceutics: barriers to drug absorption. Taylor & Francis; New York: 2001. pp. 221–247.
    1. Melchor R, Biddiscombe MF, Mak VH, Short MD, Spiro SG. Lung deposition patterns of directly labelled salbutamol in normal subjects and in patients with reversible airflow obstruction. Thorax. 1993;48(5):506–511. - PMC - PubMed
    1. Newman SP, Steed KP, Hooper G, Jones JI, Upchurch FC. Improved targeting of beclomethasone diproprionate (250 micrograms metered dose inhaler) to the lungs of asthmatics with the Spacehaler. Respir Med. 1999;93(6):424–431. - PubMed

Publication types

MeSH terms